Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway

• Main Authors: Shan-Qi Mou (Author), Zi-Ying Zhou (Author), Hong Feng (Author), Nan Zhang (Author), Zheng Lin (Author), Xiahenazi Aiyasiding (Author), Wen-Jing Li (Author), Wen Ding (Author), Hai-Han Liao (Author), Zhou-Yan Bian (Author), Qi-Zhu Tang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Liquiritin (LIQ) is a traditional Chinese medicine that has been reported to regulate inflammation, oxidative stress and cell apoptosis. However, the beneficial effects of LIQ in lipopolysaccharides (LPS)-induced septic cardiomyopathy (SCM) has not been reported. The primary goal of this...